PomDoctor (POM) to Raise $25 million in IPO

PomDoctor (POM) is planning to raise $25 million in an initial public offering on the week of August 25th, IPO Scoop reports. The company plans to issue 5,000,000 shares at $4.00-$6.00 per share.

In the last 12 months, PomDoctor generated $46.93 million in revenue and had a net loss of $5.12 million. PomDoctor has a market-cap of $592 million.

Joseph Stone Capital and Uphorizon served as the underwriters for the IPO.

PomDoctor provided the following description of their company for its IPO: “We  run an online platform in China to provide chronic disease management services. (Incorporated in the Cayman Islands) As of Dec. 31, 2024, PomDoctor had over 212,800 doctors (under contract) who had issued about 3.13 million prescriptions. The company had 699,000 patients (also referred to as transacting patients) as of Dec. 31, 2024. Our mission is to provide effective prevention and treatment solutions to alleviate patients’ suffering from illnesses. Our vision is to become the most trustworthy medical and healthcare services platform. We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan.  With focuses on chronic disease management and pharmaceutical services, our business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Our experience in tackling chronic diseases can be traced back to 2015 when we launched our platform on mobile devices. We strategically chose to focus on this field because chronic diseases last at least one year by definition, and they are hard to cure, prone to complications and require ongoing medical attention. As such, patients with chronic diseases have a great and relatively inelastic demand for frequent and repeat follow-up visits and of drug purchases, which gives a competitive advantage to platforms that are able to maintain long-term, stable doctor-patient relationships. Note: Net loss and revenue are in U.S. dollars (converted from China’s currency) for the year that ended Dec. 31, 2024. (Note: PomDoctor disclosed its IPO’s terms in an F-1/A filing dated July 15, 2025: The company is offering 5.0 million American Depositary Shares (ADS) at a price range of $4.00 to $6.00 to raise $25 million, if the IPO is priced at the $5.00 mid-point of its range. Background: PomDoctor filed its F-1 on March 13, 2025, without disclosing the terms for its IPO. and disclosed the terms for its IPO.) “.

PomDoctor was founded in 2010 and has 156 employees. The company is located at Yongxu Industrial Park No.19-23 Hejing Road, Dongsha Street Liwan District, Guangzhou 510000 People’s Republic of China and can be reached via phone at +86 020-6231 2277 or on the web at http://www.7lk.com/.